Medicare Enrolled

Dr. Nashat Rabadi, MD

Critical Care Medicine · Buffalo, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
85 HIGH ST, Buffalo, NY 14203
7166301100
In practice since 2006 (20 years)
NPI: 1669421970 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rabadi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rabadi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rabadi

Dr. Nashat Rabadi is a critical care medicine specialist in Buffalo, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rabadi performed 1,808 Medicare services across 1,478 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rabadi received a total of $538,228 from 26 pharmaceutical and/or device companies across 964 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rabadi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 11% volume in NY $538,228 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,808
Medicare services
Top 11% in NY for critical care medicine
1,478
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~90 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
592 $62 $100
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
251 $26 $88
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
245 $36 $84
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
224 $36 $83
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
222 $166 $435
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
142 $38 $61
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
63 $93 $155
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
43 $86 $151
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
14 $69 $153
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
12 $65 $180
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$538,228
Total received (2018-2024)
Avg $76,890/year across 7 years
Top 1% in NY for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
964
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$513,493 (95.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$20,235 (3.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,500 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$41,598
2023
$81,951
2022
$86,565
2021
$55,234
2020
$77,722
2019
$136,822
2018
$58,335

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Mylan Specialty L.P.
$15,610
Boehringer Ingelheim Pharmaceuticals, Inc.
$14,376
Grifols USA, LLC
$8,354
GlaxoSmithKline, LLC.
$1,591
AstraZeneca Pharmaceuticals LP
$741
Regeneron Healthcare Solutions, Inc.
$291
GENZYME CORPORATION
$259
Actelion Pharmaceuticals US, Inc.
$150
Takeda Pharmaceuticals U.S.A., Inc.
$132
Insmed, Inc.
$49
Electromed, Inc.
$46
Top 3 companies account for 92.2% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$230,705
Boehringer Ingelheim Pharmaceuticals, Inc.
$157,010
Mylan Specialty L.P.
$59,349
Grifols USA, LLC
$43,489
Sunovion Pharmaceuticals Inc.
$23,830
PFIZER INC.
$18,646
AstraZeneca Pharmaceuticals LP
$1,388
Grifols Shared Services North America, Inc.
$820
Regeneron Healthcare Solutions, Inc.
$748
GENZYME CORPORATION
$384
Actelion Pharmaceuticals US, Inc.
$379
Takeda Pharmaceuticals U.S.A., Inc.
$275
Merck Sharp & Dohme Corporation
$246
Insmed, Inc.
$217
Bayer HealthCare Pharmaceuticals Inc.
$145
Inari Medical, Inc.
$117
Mallinckrodt Hospital Products Inc.
$100
Mallinckrodt Enterprises LLC
$96
Gilead Sciences, Inc.
$85
Nabriva Therapeutics, plc
$62
Electromed, Inc.
$46
Mallinckrodt LLC
$26
United Therapeutics Corporation
$22
Sandoz Inc.
$16
Inspire Medical Systems, Inc.
$13
Teva Pharmaceuticals USA, Inc.
$13
Top 3 companies account for 83.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · Adempas · AirDuo Digihaler · Arikayce · BEXSERO · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · COMBIVENT RESPIMAT · DUPIXENT · ELIQUIS · FASENRA · FlowTriever · GLASSIA · INSPIRE · LONHALA MAGNAIR · Letairis · NUCALA · OFEV · ORENITRAM · Prolastin-C · Prolastin-C Liquid · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · TRELEGY ELLIPTA · TREPROSTINIL · UPTRAVI · UTIBRON · Utibron · Xenleta · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in critical care medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for critical care medicine in NY.

Looking for a critical care medicine specialist in Buffalo?
Compare critical care medicines in the Buffalo area by procedure volume, costs, and industry payment transparency.
Browse critical care medicines nearby

Geographic Context

Critical care medicines within 10 mi
18
Per 100K population
1.9
County median income
$71,175
Nearest hospital
KALEIDA HEALTH
1.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rabadi is a clinical cardiology specialist, with above-average Medicare volume (top 11% in NY), with speaking/promotional industry engagement in the top 1% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rabadi experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Rabadi performed 592 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rabadi receive payments from pharmaceutical companies?
Yes. Dr. Rabadi received a total of $538,228 from 26 companies across 964 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rabadi's costs compare to other critical care medicines in Buffalo?
Dr. Rabadi's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rabadi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →